Plenary Session: Successes, Challenges and
Opportunities of the Biotech Industry

• Norbert Bischofberger, Ph.D. (Executive Vice President & Chief
  Scientific Officer, Gilead Sciences): “Gilead Sciences: The Evolution
  of HIV Treatment and Gilead’s Contributions”

• Nancy Chang, Ph.D. (Chairman and Managing Director, Caduceus Asia
  partner Fund, OrbiMed Venture; Founder of Tanox): “Changing Nature of
  Pharma R&D and Outsourcing Environment in Asia”

• Karl Sanford, Ph.D. (Vice President Technology, Genencor): “Recent
  Developments in Industrial Biotechnology: From Industrial Enzymes to
  Biochemicals to Biofuels”

Scientific Session: Advances in Oncology and
Neuroscience R&D

• Ira Mellman, Ph.D. (Vice President, Research Oncology, Genentech):
  “Oncology Research at Genentech: Where Basic Science Needs No
  Translation”

• Peter Lamb, Ph.D. (Chief Scientific Officer, Exelixis): “Discovery
  and Development of Targeted Small Molecule Therapeutics for Oncology”

• Professor Dean Felsher (Stanford University): “Reversing Cancer
  through Targeted Oncogene Inactivation”

• Alexander “Sasha” Kamb, Ph.D. (Neuroscience Therapeutic Area Head,
  Amgen): “Problems and (Possible) Solutions in the Neurosciences
  Therapeutic Area”

Session on China Biotechnology and Drug Development

• Joseph McCracken, Ph.D. (Vice President, Business Development,
  Genentech): “Collaboration: a key to Genentech’s success as the
  leading biotechnology company”

• Wayne Li, Ph.D. (Morningside Group): “The State and Future of
  Biotech Funding in China”

• Jing-shan Hu, Ph.D. (Director, Licensing, Merck): “Maintaining a
  Competitive Edge in a Changing Landscape”

• Jintao Zhang, Ph.D. (President, Shanghai Medicilon): “The CRO
  Business in China Today and Tomorrow”

• Tony Zhang, Ph.D. (Managing Director and site head, China R&D, Eli
  Lilly): “Pharmaceutical R&D Networks and NME Development Efficiency”

• Yingfei Wei, Ph.D. (Chief Scientific Officer, 3SBio): “Biosimilars
  in China: Current State and Future”

• Allan Riting Liu, Ph.D. (Shanghai Fosun Pharmaceutical Group):
  “Fosun Pharma and Its Licensing and R&D Alliance Strategy”

Expert Forum & Panel Discussion on Trends in Biotechnology
and Entrepreneurship

• Mini Keynote: Brian Cunningham, J.D. (Senior Counsel and Co-Chair
  of the Life Science Group, Morrison & Foerster): “Perspective on
  Today’s BioPharmaceutical Environment”

• Distinguished Panelists: Jin-Long Chen, Ph.D. (CEO, NGM Biopharmaceuticals); Cheni Kwok, Ph.D. 
  (Senior Vice President, Poniard
  Pharmaceuticals);  Larry Wang, Ph.D. (President, GenScript); Alex Wu, Ph.D. (CEO,
  Crown BioScience)

Major Sponsors’ Presentations:

• Taicang Science Park

• Zhangjiang Biotech & Pharma Base

• GenScript

• AzoPharma

• Pharmaron